Palantir was founded with the help of CIA-backed investment fund In-Q-Tel and it attracted controversy by providing digital profiling tools for the CIA and US immigration agency ICE.

Tech giant started by US billionaire 'clinches' £480m deal to handle NHS patient information Company founded by Republican party donor Peter Thiel understood to have won lucrative, history-making ...

NHS probes potential contract breach by Palantir's unauthorized marketing campaign. Palantir's influencer initiative aimed to counter criticism and alleged misinformation. Get ahead of Wall Street ...

Controversial big data analytics firm Palantir has been awarded the £0.5 billion contract to create an NHS patient data platform, pending ministerial approval, according to health news website ...

Palantir, the $160 billion (€152 billion) US surveillance company at the centre of the farrago around suspended Social Democrats TD Eoin Hayes, is no stranger to controversy.

Palantir Stock Has Surged, but Some See Growing Reputational Risks Palantir is up 80% in 2025 amid new reports questioning its work for the US government.

NHS staff and medical trade unions have voiced concerns about Palantir ’s suitability for managing data in national health systems, given it is best known for its ties to the security, defence ...

NHS England has awarded a new contract to US data analytics company Palantir to transition existing NHS projects into a new federated data platform (FDP), prompting pushback from organisations ...

Palantir and the National Health Service didn’t respond to requests for comment. In an Aug. 25 blog post, NHS’s chief data officer said a software vendor would “never hold or have access to ...

Palantir has strong earnings, has potential for S&P 500 inclusion, and its AI Platform shows strong demand. Find out if PLTR stock is a buy.